// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

MATERNAL IBD AND IBD THERAPIES MAY INFLUENCE BREAST MILK PRO-INFLAMMATORY CYTOKINES AND THE INFAN-S FECAL CALPROTECTIN

Naomi Hotte - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

HIGH FECAL CALPROTECTIN LEVELS IN ULCERATIVE COLITIS PATIENTS IN CLINICAL REMISSION ARE ASSOCIATED WITH SPECIFIC CLINICAL AND DIETARY INTAKE PARAMETERS

Thomas Hoevers - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Ergocalciferol

RATES OF AND CLINICAL PREDICTORS OF URGENT CT FINDINGS ON ABDOMINOPELVIC CT IN EMERGENCY DEPARTMENT PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Lawrence Worobetz - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

FECAL CALPROTECTIN CORRELATES TO ENDOSCOPIC AND HISTOLOGIC REMISSION IN ULCERATIVE COLITIS: A PROSPECTIVE STUDY

Omar Kherad - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

CENTRALLY-DETERMINED STANDARDIZATION OF FLOW CYTOMETRY METHODS REDUCES INTER-LABORATORY VARIATION IN A PROSPECTIVE MULTICENTER STUDY

Tanja van Viegen - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

lonomycin

RISK FACTORS FOR VITAMIN D DEFICIENCY IN CHILDREN WITH Crohn's DISEASE OR ULCERATIVE COLITIS IN CANADA

Gao Sheng Huang - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Ergocalciferol

PERSISTENT SYMPTOMS, CRP ELEVATION AND TREATMENT CHANGES OVER TIME IN Crohn's DISEASE PATIENTS ARE ASSOCIATED WITH BOWEL DAMAGE PROGRESSION AS EXPRESSED BY DETERIORATION OF LEMANN INDEX SCORE

Tanya P. Chawla - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

N/A

N/A

Crohn's DISEASE DIAGNOSIS AFTER PROCTOCOLECTOMY AND ILEAL POUCH ANAL-ANASTOMOSIS FOR ULCERATIVE COLITIS

Carole Richard - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Mesalamine

MALADAPTIVE COPING, SELF-EFFICACY AND PATIENT REPORTED OUTCOMES IN INFLAMMATORY BOWEL DISEASE

Carolyne Lemieux - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

A POPULATION-BASED STUDY EVALUATING AN INTEGRATED MODEL OF CARE FOR INFLAMMATORY BOWEL DISEASE

Lisa Lix - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Mesalamine

IMPACT OF PATIENT REPORTED OUTCOMES, COPING STRATEGIES AND PSYCHOSOCIAL FACTORS ON MEDICATION ADHERENCE IN INFLAMMATORY BOWEL DISEASE

Carolyne Lemieux - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

DEVELOPMENT AND PILOTING OF A COGNITIVE-BEHAVIORAL SELF-MANAGEMENT PROGRAM FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE: AN EARLY STAGE UPDATE

Phylicia Verreault - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

SLEEP QUALITY IN PATIENTS WITH INACTIVE INFLAMMATORY BOWEL DISEASE REPORTING FATIGUE

Alexandra Dittrich - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

EVALUATION OF KNOWLEDGE TRANSLATION RESOURCES FOR PATIENTS ABOUT IBD AND ITS MANAGEMENT

Matthew Bernstein - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

ULCERATIVE COLITIS-ASSOCIATED ESCHERICHIA COLI COLONIZE THE INTESTINAL MUCOSA OF SUSCEPTIBLE HOST AND PROMOTE COLITIS VIA HEMOLYSIN PRODUCTION

Hyungjun Yang - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Interleukin

PLASMA GHRELIN AND LEPTIN IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND ITS ASSOCIATION WITH NUTRITIONAL STATUS

Sami Alotaibi - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

N/A

ghrelin

IMPACT OF ADIPOSITY AND GLUCOSE HOMOEOSTASIS ON ENTEROCYTES DYSFUNCTION

Sarah Beaulieu - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

citrulline

DEVELOPMENT AND FIRST INTERNATIONAL VALIDATION AND CHARACTERIZATION OF COLONIC IBD LESIONS: ADVANCED CHROMOENDOSCOPY IBD LESIONS: FACILE GROUP

Kenneth McQuaid - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

COMPARISON OF ENDOSCOPIC DYSPLASIA DETECTION STRATEGIES IN PATIENTS WITH ULCERATIVE.COLITIS: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

Parambir S. Dulai - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

PREDICTING POLYP HISTOLOGY - DEVELOPMENT AND VALIDATION OF AN INTERNATIONAL SIMPLE ENDOSCOPIC CLASSIFICATION OF SMALL COLORECTAL POLYPS USING THE NOVEL I-SCAN OPTICAL ENHANCEMENT COLONOSCOPE

Cristina Trovato - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved